Biosite hits Roche with patent litigation:
This article was originally published in Clinica
San Diego, California-based Biosite has filed a complaint against Roche Diagnostics for allegedly infringing two of Biosite's patents related to methods of measuring cardiac troponin biomarkers. Roche and Biosite are already embroiled in a separate patent dispute initiated by the former in November (see Clinica No 1133, p 15). Roche's claims against Biosite refer to a device for separating and analysing plasma or serum from whole blood and to biosensing technology for use during the process.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.